Last reviewed · How we verify

Methadone Pill

Boston Medical Center · FDA-approved active Small molecule

Methadone is a synthetic opioid agonist that binds to mu opioid receptors in the central nervous system to produce analgesia and reduce withdrawal symptoms.

Methadone is a synthetic opioid agonist that binds to mu opioid receptors in the central nervous system to produce analgesia and reduce withdrawal symptoms. Used for Opioid use disorder maintenance treatment, Chronic pain management in opioid-tolerant patients.

At a glance

Generic nameMethadone Pill
Also known asMethadone Hydrochloride
SponsorBoston Medical Center
Drug classSynthetic opioid agonist
TargetMu opioid receptor (μ-OR)
ModalitySmall molecule
Therapeutic areaPain Management; Substance Use Disorder
PhaseFDA-approved

Mechanism of action

Methadone acts as a full agonist at mu opioid receptors, producing effects similar to morphine but with a longer half-life (24-36 hours), which allows for once-daily dosing. It is primarily used in opioid use disorder treatment to prevent withdrawal symptoms and reduce cravings, and secondarily for chronic pain management. The extended duration of action makes it particularly suitable for maintenance therapy in opioid addiction.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results